Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| GALECTIN (NASDAQ: GALT) | Delayed: 3.29 +0.10 (3.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.19 | 52 Week High | $3.05 | |||
| Open | $3.21 | 52 Week Low | $0.49 | |||
| Day High | $3.33 | P/E | N/A | |||
| Day Low | $3.13 | EPS | $-1.32 | |||
| Volume | 78,712 | |||||
